March 21, 2023

Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.

March 22, 2024

OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.

April 13, 2023

The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.